Skip to content

South Korean Study to Prevent Cognitive Impairment and Protect Brain Health Through Lifestyle Intervention

A Randomized Controlled Study to Evaluate Applicability of Korean Multidomain Intervention Program in the South Korean Study to Prevent Cognitive Impairment and Protect Brain Health Through Lifestyle Intervention

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03980392
Acronym
SUPERBRAIN
Enrollment
152
Registered
2019-06-10
Start date
2019-05-29
Completion date
2020-02-25
Last updated
2021-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aged, Mild Cognitive Impairment

Keywords

prevention, dementia, intervention, mild cognitive impairment

Brief summary

This study evaluates acceptability and efficacy of multidomain intervention program to prevent cognitive impairment and protect brain health in Korean at-risk elderly. A third of participants will receive facility-based intervention for 6 months, a third will receive home-based intervention for 6 months, and a third is waiting list controls.

Detailed description

Despite extensive research in the field of Alzheimer's disease (AD), no treatment has yet been developed to modify the progression of AD. Therefore, it is important to manage vascular and metabolic risk factors, to eat healthy foods, to exercise, and to participate in social activities to prevent dementia. The FINGER study showed that the multi-domain intervention program is effective to prevent cognitive impairment and disability in elderly. In South Korea, exercise and leisure programs, and brain activity for the elderly also have been conducted in welfare centers and public health centers. However, there are not enough programs that have proven effective in the studies. So the investigators would like to develop a multi-domain intervention program and investigate applicability and efficacy before a large-scale randomized controlled trial.

Interventions

Multidomain intervention program for physical exercise, cognitive training, nutrition, vascular and metabolic risk controls, and motivation

Sponsors

Korea Health Industry Development Institute
CollaboratorOTHER_GOV
Inha University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Masking description

Independent raters are blinded to the group of participants.

Intervention model description

They will be randomly allocated to facility-based multidomain intervention group, home-based intervention group, and a regular health advice group (referred to as control group) at a ratio of 1:1:1.

Eligibility

Sex/Gender
ALL
Age
60 Years to 79 Years
Healthy volunteers
Yes

Inclusion criteria

1. Aged 60-79 2. Having at least one among the following dementia risks, * hypertension * Diabetes Mellitus * Dyslipidemia * Obesity * Abdominal obesity * Metabolic syndrome * Smoking * educational level ≤ 9 years * Physical inactivity * Social inactivity 3. Independent activities of daily living 4. Mini-Mental State Examination score better than1.5 standard deviations below age and education-adjusted normative means 5. Can read and write Korean 6. Having a reliable informant who could provide investigators with the requested information. 7. Provide written informed consent

Exclusion criteria

1. Major psychiatric illness such as major depressive disorders 2. Dementia 3. Substantial cognitive decline 4. Other degenerative disease (e.g., Parkinson's disease) 5. Malignancy within 5 years 6. Cardiac stent or revascularization within 1 year 7. Serious or unstable symptomatic cardiovascular disease 8. Other serious or unstable medical disease such as acute or severe asthma, active gastric ulcer, severe liver disease, or severe renal disease 9. Severe loss of vision, hearing, or communicative disability 10. Any conditions preventing cooperation as judged by the study physician 11. Significant laboratory abnormality that may result in cognitive impairment 12. Unable to participate in exercise program safely 13. Coincident participation in any other intervention trial

Design outcomes

Primary

MeasureTime frameDescription
retention rate (percent) of the participants6 monthsRetention rate in each intervention group
compliance (percent)6 monthsCompliance to the protocol in each intervention group
Change of cognitionChange at 6 months from baselineRepeatable Battery for the Assessment of Neuropsychological Status (sum, range 40-160) / Higher scores mean better cognition.

Secondary

MeasureTime frameDescription
Change of subjective memory complaintsChange at 6 months from baselineProspective and Retrospective Memory Questionnaire (sum, range 18-80) / Higher scores mean worse memory.
Change of memory complaintsChange at 6 months from baselineCognitive Complaint Interview (CCI) (sum, range 0-10) / Higher scores mean worse memory.
Change of prospective memoryChange at 6 months from baselineProspective Memory test (sum, range 0-12) / Higher scores mean better memory.
Change of Quality of life (QOL)Change at 6 months from baselineQOL-Alzheimer's disease (sum, rage 0-52) / Higher scores mean better QOL.
Change of activities of daily livings (ADL)Change at 6 months from baselineBayer-ADL (averaged, rage 1-10) / Higher scores mean worse ADL.
Change of global cognitionChange at 6 months from baselineMini-Mental State Examination (sum, range 0-30) / Higher scores mean better cognition.
Change of nutritionChange at 6 months from baselineNutrition Quotient for Elderly (sum, 0-100) / Higher scores mean better nutrition.
Change of balanceChange at 6 months from baselineShort Physical Performance Battery (sum, range 0-12) / Higher scores mean better physical function.
Change of physical activityChange at 6 months from baselineGlobal Physical Activity Questionnaire (This is not scoring.)
Change of motivationChange at 6 months from baselineMotivation Questionnaire subscore 1) Situational Motivation Type Scale (sum, range 4-28) / Higher scores mean better motivation. subscore 2) Self-efficacy (sum, range 4-20) / Higher scores mean better motivation.
Adverse event (number of participants)Up to 24 weeksadverse event in each group
Change of nutritional statusChange at 6 months from baselineMini Nutritional Assessment (sum, range 0-14) / Higher scores mean better nutrition.
Change of functionChange at 6 months from baselineClinical Dementia Rating scale-Sum of Boxes (sum, range 0-18) / Higher scores mean worse function.
Change of depressionChange at 6 months from baselineGeriatric depression scale-15 items (sum, range 0-15) / Higher scores mean worse emotion.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026